Concepedia

Publication | Closed Access

Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins

149

Citations

39

References

2001

Year

Abstract

The bcl-2/bcl-xL-bispecific antisense oligonucleotide 4625 merits further study as a novel compound for cancer therapy.

References

YearCitations

Page 1